Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1995-11-14
|
| pubmed:abstractText |
9-cis retinoic acid (RA) is a naturally occurring isomer of all-trans RA. While both isomers can bind with high affinity and activate RA receptors, only 9-cis RA is the specific ligand for the retinoid X receptors. 9-cis RA has also been shown to be much more potent than all-trans RA in inducing digit duplication in the chick embryo wing bud. To gain further insight into its mechanisms, here we investigated the teratogenic activity in pregnant mice of 9-cis RA and compared it with those of all-trans RA and 13-cis RA. Using frequency and severity of limb reduction defects as well as palatal clefts in the resultant fetuses as indicators, we found that orally administered 9-cis RA was one-half as potent a teratogen as all-trans RA. That 9-cis RA was intrinsically less active than all-trans RA was deduced by comparing the inhibitory activities of the two retinoids in the limb bud mesenchymal cell micromass cultures using chondrogenesis as an end-point. Since placental transfer of cis isomers of RA is generally poor, we monitored the identities and amounts of retinoids in the embryo after administration of 9-cis RA to the mother. We found that 9-cis RA undergoes extensive metabolism and isomerization during absorption resulting in a number of metabolites in the maternal circulation within 30 min after administration. Although some of these metabolites remain to be identified, the most abundant RA isomers in the plasma coeluted with 13-cis RA.(ABSTRACT TRUNCATED AT 250 WORDS)
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0040-3709
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
51
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
257-65
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:7570368-Abnormalities, Drug-Induced,
pubmed-meshheading:7570368-Animals,
pubmed-meshheading:7570368-Cell Differentiation,
pubmed-meshheading:7570368-Chromatography, High Pressure Liquid,
pubmed-meshheading:7570368-Dose-Response Relationship, Drug,
pubmed-meshheading:7570368-Embryo, Mammalian,
pubmed-meshheading:7570368-Female,
pubmed-meshheading:7570368-Isotretinoin,
pubmed-meshheading:7570368-Limb Buds,
pubmed-meshheading:7570368-Maternal-Fetal Exchange,
pubmed-meshheading:7570368-Mice,
pubmed-meshheading:7570368-Mice, Inbred ICR,
pubmed-meshheading:7570368-Placenta,
pubmed-meshheading:7570368-Pregnancy,
pubmed-meshheading:7570368-Pregnancy Outcome,
pubmed-meshheading:7570368-Stereoisomerism,
pubmed-meshheading:7570368-Teratogens,
pubmed-meshheading:7570368-Tretinoin
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Placental transfer and developmental effects of 9-cis retinoic acid in mice.
|
| pubmed:affiliation |
Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|